Concomitant Cardiac Amyloidosis in Severe Aortic Stenosis: The Trojan Horse?

Competing Interests: Author Disclosures Dr. Pibarot has received funding from Edwards Lifesciences for echocardiography core laboratory analyses in the field of transcatheter aortic valve replacement and from Medtronic for in vitro analyses, with no personal compensation. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.